Cargando…
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
Autores principales: | Delaleu, Jérémie, Deniau, Benjamin, Battistella, Maxime, de Masson, Adèle, Bensaid, Benoit, Jachiet, Marie, Lazaridou, Ingrid, Bagot, Martine, Bouaziz, Jean-David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276124/ https://www.ncbi.nlm.nih.gov/pubmed/32525093 http://dx.doi.org/10.1016/j.jaip.2020.05.046 |
Ejemplares similares
-
Hydroxychloroquine: Refractory acute generalized exanthematous pustulosis: case report
Publicado: (2021) -
Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
por: Kyriakou, Aikaterini, et al.
Publicado: (2019) -
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing
por: Charfi, Ons, et al.
Publicado: (2015) -
Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
por: Munshi, Mohammad, et al.
Publicado: (2020) -
Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
por: LAZARIDOU, Ingrid, et al.
Publicado: (2020)